Clinical Trial Update: A Study of INCB050465 in Primary Sjögren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study of INCB050465 in Primary Sjögren's Syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• INCB050465

Snippet

Sponsor: Incyte Corporation | Conditions: Primary Sjögren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-03-24